Ignite Creation Date:
2025-12-25 @ 4:09 AM
Ignite Modification Date:
2026-02-22 @ 10:03 AM
Study NCT ID:
NCT04845620
Status:
COMPLETED
Last Update Posted:
2025-12-23
First Post:
2021-04-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)
Sponsor:
Arcutis Biotherapeutics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ARQ-151-315
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None